Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

ALS is a rare, debilitating neurodegenerative disease that can affect anyone. We’ll meet a man who has been diagnosed with ALS and faces daily challenges associated with the rare disease. We’ll also hear from Dr. Steven Perrin, CEO and Chief Scientific Officer at the ALS Therapy Development Institute in Cambridge, Mass., who will explain the latest research in their dedicated efforts to seek a cure. It’s part of the Mystery Behind the Rare Disease series on the Balancing Act.

Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.

Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.

Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.

Comments

comments